Description of a Canadian employer-sponsored smoking cessation program utilizing community pharmacy-based cognitive services

Canadian Pharmacists Journal

Volumn 141, Issue 4, 2008, Pages 234-240

  Jackson, Mark ^a   Gaspic Piskovic, Marica ^a   Cimino, Sal ^a  

^a Green Shield Canada ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ADULT; BEHAVIOR THERAPY; CANADA; COMMUNITY CARE; EMPLOYER; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OCCUPATIONAL HEALTH; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; REIMBURSEMENT; REVIEW; SELF REPORT; SEX DIFFERENCE; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE;

EID: 55349103057     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X(2008)141[234:DOACES]2.0.CO;2     Document Type: Review

References (35)

1. Baliunas D, Patra J, Rehm J, et al. Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Dis Can 2007;27(4):154-62.
2. Health Canada. Canadian Tobacco Use Monitoring Survey (CTUMS) 2005. Available: www.hc-sc.gc.ca/hl-vs/tobac-tabac/research-recherche/stat/ ctums-esutc_2005_e.html (accessed June 14, 2007).
3. Fiore MC, Bailey WC, Cohen SJ, et al. Clinical Practice Guideline: treating tobacco use and dependence. Rockville, MD: US Department of Health and Human Services; June 2000. Available: www.surgeongeneral.gov/tobacco/treating⊤bacco_use.pdf (accessed April 29, 2008).
4. The Tobacco Use and Dependence Clinical Practice Guideline Panel. A clinical practice guideline for treating tobacco use and dependence - a US Public Health service report. JAMA 2000;283(24):3244-54.
5. Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use and cost effectiveness of smoking cessation services under four insurance plans in a health maintenance organization. N Engl J Med 1998;339(10):673-9.
6. Boyle RG, Solberg LI, Magnan S, et al. Does insurance coverage for drug therapy affect smoking cessation? Health Aff (Millwood) 2002;21(6):162-8.
7. Kaper J, Wagena EJ, Willemsen MC, van Schayck CP. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction 2005;100(7):1012-20.
8. National Association of Pharmacy Regulatory Authorities (NAPRA). Summary of the Scientific Rationale for Unscheduled Status of Nicotine Replacement Therapy (Chewing Gum and Transdermal Patches), July 2001. Available: www.napra.org/docs/0/92/307/336.asp (accessed May 16, 2008).
9. National Association of Pharmacy Regulatory Authorities (NAPRA). Outline of the Schedules. Available: www.napra.ca/docs/0/92/112/154/139.asp #schI(accessed April 29, 2008).
10. Ontario Ministry of Health and Long-Term Care. The Smoke-Free Ontario Act. Available: www.healdi.gov.on.ca/english/public/updates/archives/ hu_04/hu⊤bacco⋉g.html (accessed April 29, 2008).
11. Halapy H, MacCallum L. A pharmacist-run smoking cessation program. Can J Diabetes 2006;30 (4):406-10.
12. Tran MT, Holford DA, Kennedy DT, Small RE. Modeling the cost-effectiveness of a smoking cessation program in a community pharmacy practice. Pharmacotherapy 2002;22(12):1623-31.
13. Sinclair HK, Bond CM, Lennox AS, et al. Training pharmacists and pharmacy assistants in the state-of-change model of smoking cessation: a randomized controlled trial in Scotland. Tob Control 1998; 7:253-61.
14. Taylor J, Semchuk W, Neubauer S, Kuz G. Patient satisfaction with a smoking cessation program in community pharmacies. Can Pharm J 2003; 126(5):30-3.
15. Dent LA, Harris KJ, Noonan CW. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy 2007;27(7):1040-51.
16. Williams DM, Newsom JF, Brock TP. An evaluation of smoking cessation-related activities by pharmacists. J Am Pharm Assoc (Wash) 2000;40(3):366-70.
17. Hotz SB. Understanding and using the Transtheoretical Stages of Change Model. Available: www.ptcc-cfc.on.ca/pubs/RDS-0056.pdf (accessed April 29, 2008).
18. Representative Board of Saskatchewan Pharmacists Professional Practice Committee. "PACT" - Partnership for Assisting in the Cessation of Tobacco Use. Saskatoon, SK: Representative Board of Saskatchewan Pharmacists; 2005.
19. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002;288(10):1260-4.
20. General Motors Canada Limited, Durham Region Health Department, CAW. Quit Smoking Challenge. Motoring to Wellness. Fall 2006.
21. Canadian Pharmacists Association. QUIT: Quit Using and Inhaling Tobacco. Ottawa, ON: Canadian Pharmacists Association; 2006.
22. Ontario Pharmacists' Association. Clinical tobacco intervention. Available: www.opatodaycom/cti.asp (accessed April 29,2008).
23. Healthy Heart Society of British Columbia. Clinical Tobacco Intervention Recognition Program Pharmacy. Available: www.clinicalprevention.ca/ctirp/ pharmacy/index.htm (accessed April 29, 2008).
24. Preacher KJ, Briggs NE. Calculation for Fisher's exact test: an interactive calculation tool for fisher's exact probability test for 2 × 2 tables [computer software]. May 2001. Available:www.people.ku.edu/~preacher/fisher/fisher.htm (accessed April 29, 2008).
25. Sidorov J, Christianson M, Girolani S, Wydra C. A successful tobacco cessation program led by primary care nurses in a managed care setting. Am J Man Care 1997;3(2):207-14.
26. Kennedy DT, Giles JT, Chang ZG, et al. Results of a smoking cessation clinic in community pharmacy practice. JAm Pharm Assoc 2002;42(1):51-6.
27. Zillich AJ, Ryan M, Adams A, et al. Effectiveness of a pharmacist-based smoking cessation program and its impact on quality of life. Pharmacotherapy 2002;22(6):759-65.
28. Weinberger M, Murray MD, Marrero DG, et al. Issues in conducting randomized controlled trials of health services research interventions in nonacademic practice settings: the case of retail pharmacies. Health Serv Res 2002;37(4):1067-77.
29. Charrois TL, Newman SC, Senthilselvan A, Tsuyuki RT. Improving asthma control in the rural setting: the BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Can Pharm J 2006; 139(4):44-50.
30. Tornson T, Björnström C, Gilljam H, Helgason A. Are non-responders in a quitline evaluation more likely to be smokers? BMC Public Health 2005;5 (1):52.
31. Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies - report of the ISPOR Task Force on Retrospective Databases. Value Health 2003;6:90-7.
32. Graden SE, Schafermeyer KW. Performance reporting for managed care prescription programs. J Managed Care Pharm 1998;4(2):160-6.
33. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155(18):1933-41.
34. Okuyemi KS, Nollen NL, Ahluwalia JS. Interventions to facilitate smoking cessation. Am Fam Physician 2006;74(2):262-71.
35. Hey K, Perera R. Quit and Win contests for smoking cessation. Cochrane Database Syst Rev 2005;(2):CD004986.